Ashland to take sales hit of $15-20m after fire at intermediate plant

By Dan Stanton

- Last updated on GMT

Image: iStock/PJ66431470
Image: iStock/PJ66431470

Related tags Solvent

Ashland says production at a German intermediate facility hit by fire earlier this month will not restart until late September at the earliest.

A fire on August 10 at a facility in Marl, Germany, forced specialty chemicals firm Ashland to halt operations and declare “a force majeure in Europe”​ for its products 1.4 butanediol (BDO), tetrahydrofuran (THF) and formaldehyde.

The cause of the fire – which resulted in no significant injuries – is still being investigated, and production facility will continue to be suspended until late September at the earliest. The firm said it expects volume constraints for the three products to extend into the first quarter of fiscal 2018, beginning October.

“Early estimates for the loss associated with the incident, which could change as new information becomes available, are in the range of $15 - $20 million [€13 - €17m], all but several million of which will be recorded in Ashland's September fiscal quarter.”

The firm added the reduced availability is limited to BDO, THF and formaldehyde, and it is working with its affected customers to minimise any impact.

In the pharma industry, the chemical BDO and its derivatives are used as intermediates. Dehydrated BDO is used to make the intermediate Tetrahydrofuran (THF), used as a solvent in the manufacture of a number of products, for example.

The chemicals are also used in a variety of other industries for producing engineering plastics, polyurethanes, solvents and elastic spandex fibres.

Chemical dangers

Developing and working with increasingly volatile and hazardous active and inactive ingredients​ comes with safety risks.

In June​, a toxic substance leak at a solvent manufacturing facility in Pavia, Italy run by specialty chemical firm Bitolea caused 39 workers to be hospitalised after reporting burns to their respiratory tracts and eyes.

And last year​, an explosion at BASF’s Ludwigshafen, Germany site killed two employees and halted production at 20 manufacturing plants.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us